Fluoroquinolones

From Doc Moates Wiki
Revision as of 14:05, 17 June 2026 by Docmoates (talk | contribs) (NCLEX nursing pharmacology monographs — batch import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.

Fluoroquinolones — Antibacterial; Fluoroquinolone.

Identification

  • Therapeutic class: Antibacterial.
  • Pharmacologic class: Fluoroquinolone.

Pharmacology

  • Mechanism of action: Inhibit DNA gyrase and topoisomerase IV to block DNA replication (bactericidal).
  • Onset / peak / duration: Rapid; once or twice daily.
  • Half-life / therapeutic level: Levofloxacin and moxifloxacin once daily; no routine level.

Clinical use

  • Indications: Complicated urinary, respiratory, GI, and intra-abdominal infections; reserved when alternatives are unsuitable.
  • Usual dose, route, frequency: PO or IV once or twice daily.
  • Maximum dose / adjustments: Reduce cipro and levo in renal impairment; moxifloxacin not for urinary infections.

Safety

  • Contraindications: Hypersensitivity; caution with myasthenia gravis, QT prolongation, tendon disorders.
  • Black box warning: Risk of tendinitis and tendon rupture, peripheral neuropathy, central nervous system effects, and worsening of myasthenia gravis; reserve for situations with no alternative.
  • Interactions: Antacids, iron, calcium, magnesium, and dairy reduce absorption (separate doses); warfarin, theophylline (cipro raises levels), QT-prolonging drugs, NSAIDs (CNS effects).
  • Pregnancy / lactation: Generally avoided.
  • High-alert: No.

Adverse effects

  • Common side effects: Nausea, diarrhea, headache, dizziness, photosensitivity.
  • Serious effects to report: Tendon pain or rupture, neuropathy (numbness, tingling), QT prolongation, hypoglycemia or hyperglycemia, C. difficile colitis, aortic aneurysm risk.
  • Antidote / reversal: Supportive care.

Nursing process

  • Assessment before administration: Allergy, tendon and neuro history, QT and cardiac risk, glucose in diabetics.
  • Interventions during therapy: Hold and report tendon pain; separate from mineral binders; monitor glucose in diabetics.
  • Monitor: Tendons, neuro status, glucose, ECG if at risk, infection resolution.
  • Evaluation / expected outcome: Resolution of infection.

Patient teaching

  • Patient teaching: Report tendon pain, numbness, or palpitations; avoid antacids and dairy near doses; use sun protection.
  • Notify provider if: Tendon or joint pain or swelling, numbness or tingling, palpitations, chest or back pain.
  • Administration tips: Separate from antacids, iron, calcium, and dairy by at least 2 hours.